Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. EUDA
EUDA logo

EUDA

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

EUDA News

EUDA Health Price Target Cut to $2.75 by Analyst

8h agoYahoo Finance

EUDA Health Holdings Fully Repurchases Warrant

6d agoNewsfilter

ALX Oncology Gains 10.17% on Positive Phase 2 Trial Data for Evorpacept

Jan 08 2026NASDAQ.COM

EUDA Health Holdings Lowers Warrant Exercise Price to $4

Jan 07 2026Globenewswire

EUDA Launches Nationwide Stem Cell Extraction Platform, Supporting 200,000 Units Storage

Dec 30 2025Globenewswire

EUDA Launches Nationwide Stem Cell Extraction and Storage Platform, Supporting 200,000 Patients

Dec 30 2025Newsfilter

EUDA Launches Helixé 2.0 with 20% Enhanced Formula Strength

Dec 29 2025Globenewswire

EUDA Launches Helixé 2.0 with 20% Enhanced Formula Strength

Dec 29 2025Newsfilter

Davis Commodities Reports $95M Revenue in H1, Up 42.1%

Dec 26 2025Benzinga

Multi Ways Holdings Reports 87.65% Revenue Growth to $26.44 Million in H1 2025

Dec 24 2025Benzinga

EUDA Launches First Stem Cell Therapy Platform, Expands into China Market

Dec 23 2025Globenewswire

UniFirst Corp (UNF) Receives $5.2B Acquisition Proposal from Cintas (CTAS) at 64% Premium

Dec 22 2025Benzinga

U.S. Stocks Rise with Nasdaq Gaining Over 100 Points

Dec 22 2025Benzinga

EUDA Integrates QB Utility Token into Digital Health Platform

Dec 22 2025Globenewswire

Biotech Sector Sustains After-Hours Trading Gains

Dec 18 2025NASDAQ.COM

Post-Market Winners: Biotech and Med-Tech Stocks Rise on FDA Developments, Trial Clarity, and Merger Momentum

Dec 16 2025NASDAQ.COM